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ABSTRACT
Inspiratory spirometry is used in evaluation of upper airway disorders e.g. fixed or variable obstruction.
There are, however, very few published data on normal values for inspiratory spirometry. The main aim
of this study was to produce reference values for inspiratory spirometry for healthy Finnish adults.
Inspiratory spirometry was preplanned to a sample of the Finnish spirometry reference values sample.
Data was successfully retrieved from 368 healthy nonsmoking adults (132 males) between 19 and
83 years of age. Reference equations were produced for forced inspiratory vital capacity (FIVC), forced
inspiratory volume in one second (FIV1), FIV1/FIVC, peak inspiratory flow (PIF) and the ratios of FIV1/
forced expiratory volume in one second and PIF/peak expiratory flow. The present values were com-
pared to PIF values from previously used Finnish study of Viljanen et al. (1982) reference values and
Norwegian values for FIV1, FIVC and FIV1/FIVC presented by Gulsvik et al. (2001). The predicted values
from the Gulsvik et al. (2001), provided a good fit for FIVC, but smaller values for FIV1 with mean
108.3 and 109.1% of predicted values for males and females, respectively. PIF values were 87.4 and
91.2% of Viljanen et al. (1982) predicted values in males and females, respectively. Differences in meas-
urement methods and selection of results may contribute to the observed differences. Inspiratory spir-
ometry is technically more demanding and needs repeatability criteria to improve validity. New
reference values are suggested to clinical use in Finland when assessing inspiratory spirometry. Utility
of inspiratory to expiratory values indices in assessment of airway collapse need further study.
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Expiratory flow-volume spirometry is one of the most
widely used lung function measurements. It is mostly indi-
cated to measure ventilatory capacity in forced expiration,
forced vital capacity (FVC) and airflow limitation in periph-
eral intrathoracic airways. Inspiratory flow-volume spirom-
etry, which is not carried out as a screening for lung
function test, can give additional information for assessment
of central airway obstruction, fixed or variable, e.g. at larynx
[1–3]. Obstruction in the upper and central airways can
cause dyspnea and sometimes inspiratory stridor also [1,2].
In 1969 Miller and Hyatt [1,3] presented a categorization of
three characteristic patterns of flow-volume loops for major
airways obstruction: fixed lesions with equally reduced peak
inspiratory and expiratory flow, variable extrathoracic
lesions with predominantly reduced inspiratory flow and
variable intrathoracic lesions with predominantly reduced
expiratory flow . Extrathoracic lesions were at the larynx or
above the level of the suprasternal notch and intrathoracic
lesions were at or below the level of the suprasternal
notch [3].
Fixed extrathoracic obstruction may be induced by a var-
iety of conditions like bilateral vocal fold paresis and laryn-
geal tumours [1,2,4]. Variable extrathoracic obstruction can
be caused by, e.g. unilateral vocal cord paresis, polyps in the
larynx or vocal cords and vocal cord dysfunction (VCD)
[1,3,5–9]. VCD is very difficult to diagnose and often
requires provocation during laryngoscopy to confirm diag-
nosis [8]. At the symptomatic stage, it can produce a charac-
teristic inspiratory pattern of decreasing flow during
inhalation and truncated inspiratory curve, which reduces
forced inspiratory flow at 25% of inspired volume (MIF25)
in relation to forced inspiratory flow at 75% of inspired vol-
ume (MIF75) [8–10]. A normal inspiratory spirogram does
not exclude VCD. Since causes of inspiratory flow limitation
may be variable and difficult to reproduce, if more than one
abnormal inspiratory curve is recorded, structural and func-
tional evaluation has been recommended to exclude intra-
and extrathoracic upper airway obstruction [8,9].
Studies on inspiratory spirometry date mostly to early
1970 s and is thus influenced by technical development of
measuring equipment. Earlier studies used separate peak
expiratory flow (PEF) measurements using a Wright peak
flow meter adapted also to measure peak inspiratory flow
(PIF) [2,6]. Since flow-values were mostly measured from
the tracings, values such as mid-vital capacity (mid-VC)
flow ratio, measured from the flow-volume tracing at the
volume corresponding to 50% of slow vital capacity, were
used [2–4,11]. These values are not readily available from
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modern computerized spirometry systems, in which the ratio
of PIF/PEF or forced inspiratory volume in one second
(FIV1)/forced expiratory volume in one second (FEV1) are
readily available and could have diagnostic value in different
types of central airway obstructions [2,8,12]. The European
Respiratory Society (ERS)/American Thoracic Society (ATS)
Task Force in 2005 referred to the use of maximum inspira-
tory flow at 50% of FVC (MIF50) to maximum expiratory
flow at 50% of FVC (MEF50) with values below one signal-
ing variable extrathoracic obstruction and values above one
intrathoracic obstruction [13]. In some other studies, how-
ever, the use of MEF50/MIF50 has also been evaluated, but
found to have high variability, low repeatability and poor
diagnostic predictive value [9,11,14]. However, reference val-
ues of inspiratory spirometry are lacking for Caucasian peo-
ple hence determining what constitutes normal is essential.
The recently published multi-ethnic reference values of
spirometry (GLI2012) [15] do not include inspiratory meas-
urements. A Scandinavian study by Gulsvik et al. [16] repre-
sents only inspiratory reference values available, which
included only FIV1 and forced inspiratory vital capacity
(FIVC), but did not include any PIF measurements. In
Finland, previously used Viljanen et al. [17] reference values
from 1982 for spirometry included PIF and a ratio of PIF to
MEF50 . The clinical utility of the latter has not been estab-
lished, but in clinical practice the inspiratory spirometry
curve is usually visually inspected and a relationship of PIF
to PEF can be assessed. No published data is available, on
the interpretation of the PIF/PEF ratio and normal values.
The main aim of this study was to produce reference
values of healthy non-smoking Finnish adults for the
main variables measured with inspiratory spirometry: FIVC,
FIV1, FIV1/FIVC, PIF and the ratios of FIV1/FEV1 and
PIF/PEF.
Materials and methods
The protocol for spirometry reference values project has been
published before [18]. All study participants were native
Finns. Uniform inclusion and exclusion criteria were applied
to include healthy and non-smoking subjects. Only lifelong
never smokers without occupational exposure to vapors,
gases, dusts or fumes and with normal weight (body mass
index between 20 and 25 kg/m2) were included in this study.
Approvals of the study protocols were obtained from Helsinki
University Central Hospital Coordinating Ethics Committee
and Research Ethics Committee for the Hospital District of
Northern Savo (for Kuopio and Tampere) and L€ansi-Pohja
Central Hospital Ethics Committee (for Kemi). A written
informed consent was obtained from all participants.
At all centers, namely Helsinki, Kemi, Kuopio and
Tampere, inspiratory spirometry measurements were origin-
ally planned. In Kuopio, every fourth subject was invited to
complete a separate measurement of forced inspiratory spir-
ometry after expiratory spirometry. In Helsinki and Kemi,
all subjects participating in the population based studies
were included, but since inspiratory spirometry was technic-
ally more demanding, only a smaller proportion of the
healthy nonsmoking adults managed to complete a technic-
ally satisfactory measurement. Inspiratory spirometry was
completed in conjunction with the expiratory spirometry in
loops. If the participant was not able to perform satisfactory
loops, inspiratory spirometry was discarded. From Tampere
and Kemi, the data could not be satisfactorily verified for
quality control and hence were excluded from this study.
Only spirometry measurements that could be quality con-
trolled from original printouts were accepted.
Identical Vmax 22D spirometers (heated wire flow trans-
ducer spirometer) were used in each study center (Sensor
Medics Corporation, Yorba Linda, CA). Spirometers were
calibrated every day in the morning. All the measurements
were done following the 1994 ATS Standard [19].
Spirometry standards do not have repeatability or quality
control criteria for inspiratory spirometry [13,19,20]. All
measurements were visually controlled and to be acceptable
the best inspiratory curve was required to be with one clear
peak with good effort. No preconceived PIF or FIV1 limits
were imposed. From acceptable curves, the highest FIVC,
FIV1 and PIF were selected. If inspiratory time was under
1 s, the spirometer did not report a FIV1. In these situations,
FIV1 was considered equal to FIVC. The ratio of FIV1/
FIVC was calculated from the selected best values. Similar
repeatability criteria were considered for inspiratory maneu-
vers as a set for expiratory measurements with two best
FIVC and FIV1 values aimed within 200ml and two best
PIF within 20%. Three acceptable measurements were aimed
for with a maximum of eight efforts. Repeatability was
required at measurements undertaken in Kuopio and to be
accepted for the study there had to be at least two parallel
inspiratory measurements fulfilling the repeatability criteria.
For Helsinki, the curves were individually manually checked
since the software automatically selected the inspiratory val-
ues of best expiratory maneuver as the best inspiratory man-
euver. Repeatability criteria for inspiratory spirometry could
not be implemented at the time of the actual measurements,
but the same inspiratory value repeatability criteria as in
Kuopio were implemented when screening acceptable spi-
rometry’s for this study.
The variables analyzed were FIVC, FIV1, FIV1/FIVC,
PIF, PIF/PEF and FIV1/FEV1. Various modelling
approaches were evaluated including the Generalized
Additive Model for Location, Scale and Shape (GAMLSS)
model used in the development of the Global Lung Function
Initiative (GLI) reference values. The simplest model result-
ing in highest degree of determination was chosen.
Predictors were included in the model in a stepwise manner
and retained in the final model if they improved the degree
of determination significantly. Predicted mean and 5th per-
centile lower limit of normal (LLN) were calculated using a
linear regression model using the Equation (1):
f ¼ a0þ a1 sexþ a2 ageþ a3 ln ageð Þ þ a4 height
(1)
with a0, a1, a2, a3 and a4 are the regression coefficients.
Measured values were presented as percent of predicted values
from this study and the currently used Viljanen et al. [17]
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reference value for PIF and published reference values of
Gulsvik et al. [16] for FIVC, FIV1, and FIV1/FIVC were
compared using the Wilcoxon Signed Ranks test.
All statistical analyses were conducted using the statistical
program SPSS (IBM SPSS Statistics for Macintosh, Version
22.0. Armonk, NY: IBM Corp.). Chi-squared test was used
for categorical comparisons. Normality was tested with
Shapiro-Wilks test for normality and comparison of con-
tinuous variables was done with Students t-test for normally
distributed variables and Wilcoxon Signed Rank test for
non-normally distributed variables. A p value of .05 was
chosen for all comparisons. Data on differences between
predicted values of PIF from this study and the currently
used Viljanen et al. [17] reference values are presented as
Bland-Altman plot [21].
Results
Descriptive statistics of the study population are presented
in Table 1. Since Kuopio specifically recruited healthy older
subjects in the reference values study, the participating sub-
jects in Kuopio were older 52.7 (SD 18.0) vs. 47.5 (SD 12.8)
years (p¼ .001) and shorter 167.3 (SD 9.4) vs. 169.6 (SD
9.0) cm (p¼ 0.016) than in Helsinki. Between-center differ-
ences were evaluated by modelling PIF for the combined
data and for both centers separately as illustrated in
Figure 1 for males and females. The crude PIF values for
Helsinki were larger and in relative to Viljanen et al. refer-
ence values [17] smaller than in Kuopio, but after taking
into account the sex, age and height of the subjects, these
differences were not significant.
The measured values of FIVC, FIV1, PIF and the ratios
of FIV1/FVC, FIV1/FEV1 and PIF/PEF are shown in
Figure 2 stratified by sex. Regression coefficients for the pre-
diction models for FIVC, FIV1, PIF, FIV1/FVC, FIV1/FEV1
and PIF/PEF are presented in Table 2.
There are very little published data on inspiratory spir-
ometry and in comparison to previously published and used
values can thus be presented only for two studies: Gulsvik
et al. (2001) for FIV1, FIVC and FIV/FIVC and Viljanen
et al. (1982) for PIF [16,17]. In Figure 3 the predicted values
from Gulsvik et al. [16] are compared to models presented
in this study for average height of males and females for
FIV1, FIVC and FIV1/FIVC. The predicted values from this
study are slightly larger in females and in older adults. The
PIF values predicted by Viljanen et al. [17] are slightly larger
especially in younger adults, but the difference diminishes
with age as illustrated in Figure 4(a). In the study partici-
pants, the Viljanen et al. [17] predicted values produced
consistently larger values than the predicted values from the
present study, with a larger difference in subjects with
higher PIF values as shown in the Bland-Altman graph in
Figure 4(b). The predicted values for the reference values
sample from Gulsvik et al. [16] and Viljanen et al. [17] and
also the models from the present study are presented in
Table 3. The predicted values by Gulsvik et al. [16], provide
a good fit for FIVC, but significantly smaller values for
FIV1 with a mean 108.3 and 109.1% of predicted values for
males and females, respectively (p< .001). This difference
could be partially influenced by measurement methods,
which could thereby influence the also found differences in
FIV1/FIVC.
Discussion
Inspiratory spirometry is seldom used, but when used needs
reference values to identify deviations from normal values.
To date there has been very limited data to define normality.
In this study, reference equations for main inspiratory spir-
ometry variables and their ratios to the expiratory equiva-
lents are presented for clinical use.
Inspiratory spirometry is technically more demanding
than the expiratory maneuver. Gulsvik et al. [16] have
shown in their study that the intraindividual variation in
FIV1 is greater than of that in FEV1 and repeatability is dif-
ficult to achieve. These results support the need for this
finding. Spirometry standards have no repeatability or qual-
ity criteria for the inspiratory maneuvers. No preconceived
limits for acceptable PIF levels were chosen, but a good
curve with one clear peak was required. The resulting PIF
levels were lower than expected when compared to previ-
ously used Viljanen et al. [17] predicted values. However,
the FIV1 and FIVC levels were very close to the values pre-
dicted by Gulsvik et al. [16] thus this seems to be a naturally
occurring phenomenon and does not necessarily represent
poor effort or quality.
In Kuopio, inspiratory measurements were done separ-
ately as loops, meaning that the subject did a forced inspira-
tory maneuver immediately after the forced expiratory
maneuver, with repeatability criteria similar to the expiratory
Table 1. Descriptive statistics of the study population. Data presented as mean (SD).
Male (n¼ 132) Female (n¼ 236)
Mean (SD) Min–max Mean (SD) Min–max p value
Age, years 50.9 (15.7) 20.8–82.1 49.1 (15.4) 19.0–83.2 .289
Height, cm 177.4 (7.1) 157.5–194.0 163.7 (6.1) 149–179 <.001
Weight, kg 78.4 (11.6) 52–108 64.8 (9.5) 42.1–94.8 <.001
BMI, kg/m2 24.8 (2.8) 17.8–29.9 24.2 (3.0) 17.7–29.8 .073
FIVC, L 4.98 (0.85) 2.75–6.87 3.43 (0.62) 1.85-5.08 <.001
FIV1, L 4.64 (0.87) 2.11–6.56 3.14 (0.63) 1.51-4.61 <.001
FIV1/FIVC, % 93.1 (5.4) 77.0–100.0 91.3 (6.2) 69–100 .007
PIF, L/s 7.35 (1.83) 2.47–12.52 4.90 (1.12) 2.47–7.59 <.001
PIF/PEF, % 70.2 (13.6) 33.9–108.7 68.8 (13.1) 36.9–100.8 .341
FIV1/FEV1, % 113.4 (10.6) 87.2–142.2 109.9 (11.7) 79.7–155.9 .005
BMI: body mass index; FIVC: forced inspiratory vital capacity; FIV1: forced inspiratory volume in one second; PIF: peak
inspiratory flow; PEF: peak expiratory flow; FEV1: forced expiratory volume in one second.
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maneuvers applied to inspiratory values. In Helsinki, the
inspiratory maneuvers were done as loops in conjunction
with the expiratory spirometry with best curves selected
based on expiratory maneuver quality and repeatability crite-
ria. In the Norwegian study by Gulsvik et al. [16] inspiratory
measurements were also done as loops and selection of best
maneuvers was done primarily based on the expiratory limb
of the measurement. The spirometry software does not per-
mit selecting best inspiratory and expiratory parts from sep-
arate maneuvers. In this study, the best inspiratory
maneuvers in Helsinki were thus selected manually after-
wards by visual inspection of all curves. Equivalent repeat-
ability criteria were strived for, but could not be effectively
enforced. The predicted values from Kuopio measurements
were slightly higher, but the difference between the centers
was not significant after controlling for sex, age and height
of the subjects. However, since the inspiratory measurements
as loops were significantly more difficult for the subjects, it
would seem reasonable to recommend doing the inspiratory
maneuvers, when indicated, as separate measurements after
establishing the subjects FEV1 and peak flow to ensure
accurate baseline for comparison. Since measurement vari-
ability is even larger than in expiratory spirometry, repeat-
ability criteria for the measurements should be also defined
to improve the validity of measurements done at different
locations or time points.
The predicted values from the Norwegian study by
Gulsvik et al. [16], provided a good fit for FIVC in this sam-
ple, but smaller values for FIV1 with a mean of 108.3 and
109.1% of predicted values for males and females,
(a)
(b)
Figure 2. Predicted peak inspiratory flow (PIF) and lower limit of normal (LLN) for the combined sample and for Kuopio and Helsinki centers modelled separately
for (a) males (177 cm) and (b) females (164 cm) in height.
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respectively. Differences in measurement methods and selec-
tion of results may contribute to this observed difference. In
the study by Gulsvik et al. [16] the quality criteria had been
selected to so that the FIVC needs to be within 200ml of
the largest FVC. Smaller proportion of the subjects com-
pleted acceptable FIV1 than FIVC, but there is no indication
in study methods how maneuvers with inspiratory time
under one second were handled. In this study, it was
decided from the outset that FIVC would be substituted for
FIV1, if the inspiratory time in a good maneuver was under
one second. This may have influenced the observed differen-
ces in FIV1 and FIV1/FIVC between these studies.
In this study several indices reflecting differences between
inspiratory and expiratory spirometry are presented. The
ratio PIF/PEF is used in clinical practice and reflects possible
extrathoracic airway stenosis, although there are very few
published studies using spirometry [5]. The relationships
between FIV1/FEV1 or FIVC/FVC are even less studied, but
it is hypothesized that these indices could prove useful in
selected clinical situations e.g. in the evaluation of variable
extra- or intrathoracic airway obstruction or collapse in phe-
notyping severe asthma [2,4,8,12]. Further study is needed
to assess their usability. Since the reproducibility of the
inspiratory values has been found poorer than expiratory
spirometry even with FIV1 and FIVC, the measurement of
MIF50 and MEF50, both of which are highly dependent on
volume changes in the respective inspiratory and expiratory
maneuvers, the MIF50/MEF50 ratio was not separately mod-
elled [16]. It should also be noted that all the inspiratory-
expiratory ratios also have low degrees of determination in
this study.
Since there are very little published data on inspiratory
spirometry, these values cannot be compared to other pub-
lished indices. In the study by Gulsvik et al. [16] FEV1/FIV1
ratio was found to be higher in females than in males while
the FIV1/FIVC was lower in females and this was suggested
to be caused by men having more respiratory musculature
than females. The findings from this study are concurrent
with this with males having higher predicted values in FIV1/
FIVC and FIV1/FEV1. Height didn’t significantly contribute
to the prediction models in these variables and was thus
excluded (Table 2). However, in PIF/PEF, height affects pre-
dicted values with taller subjects having higher predicted
PIF/PEF ratio and the predicted PIF/PEF values were con-
sistently smaller for same height males compared to females.
Clinical studies have evaluated the usefulness of different
indices to detect upper airway disease noninvasively from
flow-volume spirometry. Modrykamien et al. [14] evaluated
four quantitative and three visual criteria, but the only
inspiratory flow value used was MIF50, which has high
measurement variability . Quantitative criteria showed low
sensitivity for detection, but exceeded that of visual criteria
Table 2. Regression coefficients for reference equations for mean and lower
limit of normal (LLN) for the inspiratory spirometry variables.
Variable Constant Sexa Age Ln (age) Height R2adj
FIVC, L
Mean 7.203 0.825 0.036 0.938 0.054 76.8%
LLN 8.409 0.815 0.044 1.351 0.053
FIV1, L
Mean 7.711 0.847 0.045 1.307 0.049 75.0%
LLN 8.956 0.836 0.054 1.734 0.049
FIV1/FIVC, %
Mean 61.412 1.874 0.345 12.202 – 7.6%
LLN 46.457 1.687 0.448 17.132 –
PIF, L/s
Mean 15.892 1.500 0.107 3.719 0.072 60.1%
LLN 18.561 1.498 0.110 3.858 0.072
PIF/PEF,%
Mean 72.393 3.461 0.783 31.366 0.362 9.3%
LLN 103.270 3.722 1.004 41.949 0.352
FIV1/FEV1,%
Mean 48.529 3.055 0.148 17.880 – 12.0%
LLN 20.525 2.705 0.341 27.112 –
aMale¼ 1; Female¼ 0.
R2adj: degree of determination; LLN: lower limit of normal; FIVC: forced inspira-
tory vital capacity; FIV1: forced inspiratory volume in one second; PIF: peak
inspiratory flow.
Figure 3. Measured peak inspiratory flow (PIF) values expressed as percent predicted of (a) Viljanen et al., 1982 reference values, (b) predicted values derived from
this study for healthy nonsmoking adults.
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[14]. Suspected VCD is commonly sought to verify with
inspiratory spirometry, but poses great challenges as the
condition itself is highly variable and produces typical
changes to inspiratory flow values only when symptomatic
[8]. MIF25/MIF75 ratio was the only index predictive of
VCD and even that lost significance after controlling for
reproducibility of the inspiratory manouvers [8]. This might
be influenced by the high variability of the physiologic phe-
nomenon as no provocation has been used before spirom-
etry to precipitate the findings [8,9]. Normal inspiratory
spirometry does not exclude VCD and further study is
always recommended when more than one abnormal
inspiratory maneuver is recorded [8,9]. Unilateral fixed vocal
cord paralysis has been shown to produce fixed extrathora-
cic airway obstruction i.e. constantly reduced PIF in relation
to PEF [5].
Study limitations
This study includes 368 adults, of whom only 132 were
male. The small study sample poses limitations to applicable
modelling approaches and generalizability of the results.
However, there are limited data available on inspiratory
spirometry and thus this small sample is seen of value to
gain some insight to normative values in the inspiratory
maneuvers. There are also very limited studies on the quality
criteria, repeatability and clinical interpretation of inspira-
tory spirometry, which would warrant further study beyond
the scope of this manuscript.
Conclusion
Inspiratory spirometry is technically more demanding than


















present study male 177cm
Viljanen male 177cm
present study female 164cm
Viljanen female 164cm
(a) (b)
Figure 4. (a) Predicted peak inspiratory flow (PIF) values from Viljanen et al. [17] and values from the present study for males (177 cm) and females (164 cm).
(b) Bland-Altman graph [21] showing the difference between PIF predicted with Viljanen et al. [17] reference values and values derived from the present study in
relation to their mean. Horizontal solid line indicating the mean and dashed lines indicating the 95th percentile confidence limits.
Table 3. Predicted values in the study population of healthy nonsmoking adults. Comparison between reference models presented with Wilcoxon Signed Rank
test.
Male (n¼ 132) Female (n¼ 236)
Mean (SD) 95% CI for mean Mean (SD) 95% CI for mean p valuea
FIVC
Present study 99.3% (12.6%) 97.1–101.5 99.1% (11.8%) 97.6–100.6 Male: .064 Female: .044
Gulsvik et al. [16] 101.3% (14.1%) 98.8–103.7 99.3% (12.2%) 97.7–100.8
FIV1
Present study 100.5% (13.9%) 98.1–102.9 100.9% (14.1%) 99.1–102.7 Male: < .001 Female:< .001 .001
Gulsvik et al. [16] 108.3% (17.6%) 105.3–111.3 109.1% (17.6%) 106.8–111.3
FIV1/FIVC
Present study 97.6% (5.5%) 96.6–98.5 97.6% (6.5%) 96.8–98.5% Male: <.001 Female: <.001
Gulsvik et al. [16] 105.9% (6.5%) 104.7–107.0% 109.4% (7.6%) 108.4–110.4%
PIF
Present study 99.3% (19.5%) 96.8–102.7% 100.3% (20.5%) 97.6–102.9% Male: <.001 Female: <.001
Viljanen et al. [17] 87.4% (17.6%) 84.4–90.5 91.2% (18.4%) 88.8–93.5
PIF/PEF
Present study 99.9% (17.6%) 96.8–102.7 100.1% (18.6%) 97.7–102.4
FIV1/FEV1
Present study 100.0% (8.8%) 98.5–101.5 100.0% (9.9%) 98.7–101.3
CI: confidence interval; FIVC: forced inspiratory vital capacity; FIV1: forced inspiratory volume in one second; FEV1: forced expiratory volume in one second;
PIF: peak inspiratory flow; PEF: peak expiratory flow.
aWilcoxon Signed Rank test.
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validity. Prediction equations are given for main inspiratory
spirometry variables and also for their ratios to the respect-
ive expiratory values. Usability of these indexes requires fur-
ther study.
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